Canon U.S.A CR-2 receives clearance from FDA

November 16, 2010 by | Comments

November 16, 2010 – Canon U.S.A., Inc., a leader in digital imaging, today announced the Canon CR-2 Digital Non-Mydriatic Retinal Camera has received 510(k) clearance from the U.S. Food and Drug Administration (FDA)1.

Integrating the latest in Canon’s retinal imaging technology and enhancements in a compact frame, the Canon CR-2 Digital Non-Mydriatic Retinal Camera is the Company’s newest and lightest retinal camera to date, weighing only 33 pounds. The CR-2 retinal camera can be easily installed or for added convenience, can be easily transported when needed. The illuminated control panel allows medical staff to easily navigate operations in darkened rooms. Contributing to a lower total-cost-of-ownership, the white LED lamp used in the CR-2 retinal camera uses less power than a xenon tube and lasts approximately twice as long, which can help to reduce energy costs in medical facilities.

“Obtaining FDA clearance of the CR-2 Digital Non-Mydriatic Retinal Camera helps reaffirm our commitment to eye care professionals by instituting superb imaging technology and in turn, contributing to the quality care of their patients.” said Tsuneo Imai, senior director and general manager, Medical Systems Division, Canon U.S.A.

The CR-2 Digital Non-Mydriatic Retinal Camera joins Canon’s complete line of total digital imaging solutions and workflow management solutions for ophthalmic professionals. The CR-2 retinal camera is available for purchase through authorized Canon dealers. For more information about Canon ophthalmic devices and solutions, please go to www.usa.canon.com/eye-care.

–(Canon U.S.A. Inc. Press Releases)–

Enjoyed it? Share it!

Digg facebook delicious live
google linkedin myspace reddit
stumble technorati twitter Yahoo
This page is archived in:

- Events - Feeds - Imaging - News 

Stay Tuned...
RSS
RSS
e-Mail